Neursantys stands at the forefront of non-invasive bioelectronics, addressing neuromotor and neurocognitive conditions lacking widespread pharmacological solutions. Our flagship product platform, NEURVESTA, delivers the world’s first restorative neuroplastic treatment for age-related balance decline, a medical condition that is now known to begin as early as age 40 and affect over 70 million people in Canada and the U.S. alone.
Industry
Medical Equipment Manufacturing, Specialty (except Psychiatric and Substance Abuse) Hospitals, Health Care and Social Assistance
HQ Location
659 Oak Grove Ave
Menlo Park, California 94025, US
Keywords
BioelectonicsNeuroscienceAgeTechSportsTechSpace Medicinevestibular dysfunctionwearable devicemedical devicesphysical therapytherapeutic treatment